Skip to content

Clinical trials

Depressive Disorder trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Country / region: Australia Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20082
20092
20112
20121
20151
20212
20221
20232
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting4
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Eli Lilly and Company2
Praxis Precision Medicines2
Takeda2
The University of New South Wales2
Australian National University1
Cervel Neurotech, Inc.1
Cybin IRL Limited1
Digestome Therapeutics1
H. Lundbeck A/S1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder20
Major Depressive Disorder12
Mood Disorders8
Mental Disorders2
Anxiety Disorders1
Bipolar Disorder1
Depressive Disorder, Treatment-Resistant1
Dysthymic Disorder1
Epilepsy1
Schizophrenia1

Trials

Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.